IP Library Granted Patent US 11,058,484
Granted Patent B2
US 11,058,484 · App. 16/571,939 · Granted Jul 13, 2021

Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury

Inventors: Samuel J. Asirvatham (Rochester, MN); Mark B. Knudson (Shoreview, MN)
Assignee: Mayo Foundation for Medical Education and Research
A61B18/1492A61N1/0551A61N1/20A61B2018/00363A61B2018/00577A61B2018/00642A61B2018/0212A61B2018/1266A61B2018/1472A61N1/36057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,058,484
App. No.
16/571,939
Granted
Jul 13, 2021
Kind
B2
Abstract

A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space. The device performs modulation or ablation of the autonomic nervous system at selected treatment areas within the pericardium.

Claims (17)

1. A device for modulating an autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia of a heart, the device comprising:

a source of non-thermal DC electrical energy configurable to generate non-thermal DC electrical energy with a pulsation frequency of between 5 kHz and 10 kHz, inclusive, and a current level between 3,000 microamps to 5,000 microamps so as to modulate the autonomic nervous system without causing damage to myocardial or pericardial tissue;

a catheter having a proximal end and a distal end, the distal end sized for insertion into the pericardial space;

a delivery assembly, the delivery assembly having a proximal end and a distal end, the distal end of the delivery assembly arranged to be positioned by the distal end of the catheter, the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space;

a plurality of electrodes disposed on the delivery tip; and

an electrical connection operatively coupling the plurality of electrodes to the source of non-thermal DC electrical energy.

2. The device of claim 1 , wherein the source of non-thermal DC electrical energy is configurable to generate non-thermal DC electrical energy with a frequency between 6 kHz and 8 kHz, inclusive.

3. The device of claim 1 , wherein the source of non-thermal DC electrical energy is configurable to generate non-thermal DC electrical energy with a frequency 7 kHz.

4. The device of claim 1 , wherein the source of non-thermal DC electrical energy is synchronizable with a QRS complex of the heart.

5. The device of claim 1 , further comprising:

one or more apertures disposed on the delivery tip; and

a channel coupled to the one or more apertures and configured to deliver a solution via the one or more apertures into the pericardial space adjacent an epicardial surface.

6. The device of claim 1 , further comprising:

an electrode disposed on the delivery tip and electrically coupled to a sensing circuit configured to detect activity of a ganglia on an epicardial surface.

7. The device of claim 1 , further comprising:

a monitoring and control system electrically coupled to the delivery tip and operable to control the source of non-thermal DC electrical energy.

8. The device of claim 7 , wherein the monitoring and control system is further operable to configure the source of non-thermal DC electrical energy to have a selected amplitude and a selected frequency.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2020
From: ASIRVATHAM, SAMUEL J.; KNUDSON, MARK B.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 054709/0904 →
Continuity (5)
Continuation 14784509
Provisional Application 61823347 · May 14, 2013
Provisional Application 61817775 · Apr 30, 2013
Provisional Application 61812114 · Apr 15, 2013
Related Publication 20200022752A1 · Jan 23, 2020
Cited By (14)
US 12,217,863 US 12,257,071 US 12,279,889 US 12,369,852 US 12,369,859 US 12,376,757 US 12,408,974 US 12,433,670 US 12,471,776 US 12,478,806 US 12,539,167 US 12,544,131 US 12,611,134 US 12,714,780